Patent · US Active

Combined drug delivery methods and apparatus

US10617557B2 · kind B2 · utility

2Cited by

167References

20Claims

0Family size

Assignee

ForSight Vision4, Inc. · US

Inventors

Eugene de Juan, Jr. · San Francisco, US
Yair Alster · Menlo Park, US
Kathleen Cogan Farinas · Menlo Park, US
Cary J. Reich · Los Gatos, US
Randolph E. Campbell · South San Francisco, US
K. Angela Macfarlane · Menlo Park, US
Signe Erickson · Menlo Park, US

Key dates

Filing date	Aug 5, 2011
Grant date	Apr 14, 2020
Priority date	—
Expiry date	Feb 21, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61F2250/0068
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and apparatus provide treatment with a first therapeutic agent and a second therapeutic agent for an extended time. The first therapeutic agent may comprise a VEGF inhibitor and the second therapeutic agent may comprise an antiinflammatory, such as a non-steroidal anti-inflammatory, for example a cyclooxygenase inhibitor. One or more of the first therapeutic agent or the second therapeutic agent can be injected into the eye, for example injected into a therapeutic device implanted into the eye to release the injected therapeutic agent for an extended time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.